College
School of Osteopathic Medicine
Keywords
Urinary Bladder Neoplasms, Neoadjuvant Therapy, Cystectomy, Quality Improvement, Anastomotic Leak
Date of Presentation
5-5-2022 12:00 AM
Poster Abstract
Muscle-invasive bladder cancer (MIBC) represents approximately 25% of all bladder cancer and carries a significant risk of mortality. Neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) is the standard of care for MIBC. One complication associated with RC is ureteral anastomotic leak with a predicted rate of 3%. The objective of this National Surgical Quality Improvement Project (NSQIP) database analysis is to determine if correlations exist between radiation (RAD) and/or NAC before RC and anastomotic leak in the treatment of MIBC.
Disciplines
Health and Medical Administration | Medicine and Health Sciences | Neoplasms | Oncology | Surgery | Urogenital System | Urology
Included in
Health and Medical Administration Commons, Neoplasms Commons, Oncology Commons, Surgery Commons, Urogenital System Commons, Urology Commons
Neoadjuvant Chemotherapy as a Risk Factor for Urinary Anastomotic Leak in Patients Undergoing Radical Cystectomy
Muscle-invasive bladder cancer (MIBC) represents approximately 25% of all bladder cancer and carries a significant risk of mortality. Neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) is the standard of care for MIBC. One complication associated with RC is ureteral anastomotic leak with a predicted rate of 3%. The objective of this National Surgical Quality Improvement Project (NSQIP) database analysis is to determine if correlations exist between radiation (RAD) and/or NAC before RC and anastomotic leak in the treatment of MIBC.
